June 2, 2017 / 8:16 PM / in 2 months

BRIEF-Newlink reports Results from clinical trial of indoximod plus chemotherapy

1 Min Read

June 2 (Reuters) - Newlink Genetics Corp:

* Results from clinical trial of indoximod plus chemotherapy for patients with metastatic breast cancer

* Newlink Genetics Corp - ‍top line data from study show that trial did not meet its pre-specified endpoints​

* Newlink Genetics Corp - ‍results from a phase 2 trial of indoximod in combination with taxane chemotherapy for patients with metastatic breast cancer​ Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below